deoxycytidine


Also found in: Dictionary, Thesaurus, Wikipedia.
Related to deoxycytidine: deoxycytidine monophosphate, deoxythymidine

de·ox·y·cyt·i·dine

(dē-oks'ē-sī'ti-dēn),
2'-Deoxyribosylcytosine, one of the four major nucleosides of DNA (the others being deoxyadenosine, deoxyguanosine, and thymidine).

de·ox·y·cyt·i·dine

(dē-oks'ē-sī'ti-dēn)
One of the four major nucleosides of DNA (the others being deoxyadenosine, deoxyguanosine, and thymidine).
References in periodicals archive ?
1) The level of methylated deoxycytidine (5mdC) in the genome changes with age in many tissues, but this does not apply to all tissues of different mammalian species.
Takeda K, Kurata N, Kuwabara T, Kobayashi S, Fukuoka M (1998) Interleukin 6 is a cause of flu-like symptoms in treatment with a deoxycytidine analogue.
deoxynucleotide triphosphates (dNTPs), which are the nucleotides deoxyadenosine triphosphate (dATP), deoxyguanosine triphosphate (dGTP), deoxycytidine triphosphate (dCTP), and deoxythymidine triphosphate (dTTP) that compose DNA.
In vivo, Ara-C is transported into the cell via the human equilibrium nucleoside transporter (hENT1) and is rapidly phosphorylated by deoxycytidine kinase (dCK) to its monophosphate form, cytosine arabinoside monophosphate (Ara-CMP), which is further phosphorylated by nucleoside kinases and finally to the triphosphorylated and active form, cytosine arabinoside triphosphate (AraCTP).
A healthy population of 100 individuals of Hungarian origin was investigated for genotype frequencies for two important polymorphisms in the deoxycytidine Kinase gene.
This result is reasonable because in vitro resistance to AraC is generally explained by the inactivation of deoxycytidine kinase, whereas resistance to DNR has been explained as an overproduction of multidrug efflux pumps, such as P-glycoprotein or multidrug-resistance protein (13).
Malondialdehyde, one of the most abundant carbonyl products, can react with DNA to form adducts with deoxyguanosine, deoxyadenosine, and deoxycytidine that are mutagenic in bacterial and mammalian cells.
2026: Phase I and pharmacokinetic trial of oral administration of CYC682, a novel 2' deoxycytidine type anti-metabolite pro-drug, in patients with advanced solid tumors or lymphoma.
5 mM magnesium chloride, 200 [micro] Meachof deoxyadenosine triphosphate, deoxycytidine triphosphate, deoxyguanosine triphosphate, and thymidine monophosphate.
The most significant enzyme that takes part in Ara-C phosphorylation is deoxycytidine kinase (dCK) (5) (29).
The genomic modification process converts all deoxycytidine residues to deoxyuridine.
There are three classes of anticancer agents on the market that are analogous to CYC682: fluorouracil analogs, like capecitabine and 5-FU; 2 deoxycytidine analogs, like cytarabine and gemcitabine, the market leading nucleoside analogue; and purine analogs, like 6-mercaptopurine.